L&D Tech Selected as a World-Class Product with Its Energy-Saving LED Display; Receives Prime Minister's Award and Announces Global Launch
Awarded the Prime Minister's Prize for New Technology Commercialization at the Industrial Technology Merit Awards, validating its technological excellence and reliability Proprietary 3D-structured lens technology reduces light pollution and cuts...
One Lantern, Three Destinations! 3.2 Million Fans Follow IN XI'AN to Discover a City Where Ancient Meets Modern
XI'AN, China, Oct. 28, 2025 /PRNewswire/ -- In August 2025, Xi'an's overseas social media account IN XI'AN launched the special campaign "One Light, One Journey," focusing on cultural resonance across Chinatowns in San Francisco, London, and Milan....
Bambusa Therapeutics Announces First Subject Dosed in Phase 1 Clinical Trial of BBT001, a Novel Multi-Targeting, Half-Life Extended Bispecific Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory Skin Diseases
Preclinical data with BBT001 demonstrate its best-in-disease potential for improved efficacy and dosing convenience compared to approved biologics in atopic dermatitis Interim safety and pharmacokinetic data from healthy volunteers anticipated in 2H...